+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019

  • PDF Icon

    Report

  • 126 Pages
  • December 2019
  • Region: Global
  • GlobalData
  • ID: 4898084
Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Cataract Surgery Devices - Medical Devices Pipeline Assessment, 2019“ provides an overview of Cataract Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cataract Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cataract Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cataract Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cataract Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Introduction
1.1 Cataract Surgery Devices Overview
2 Products under Development
2.1 Cataract Surgery Devices - Pipeline Products by Stage of Development
2.2 Cataract Surgery Devices - Pipeline Products by Segment
2.3 Cataract Surgery Devices - Pipeline Products by Territory
2.4 Cataract Surgery Devices - Pipeline Products by Regulatory Path
2.5 Cataract Surgery Devices - Pipeline Products by Estimated Approval Date
2.6 Cataract Surgery Devices - Ongoing Clinical Trials
3 Cataract Surgery Devices - Pipeline Products under Development by Companies
3.1 Cataract Surgery Devices Companies - Pipeline Products by Stage of Development
3.2 Cataract Surgery Devices - Pipeline Products by Stage of Development
4 Cataract Surgery Devices Companies and Product Overview
4.1 Advanced Refractive Technologies Inc Company Overview
4.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
4.2 Altacor Ltd Company Overview
4.2.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.3 Bausch & Lomb Inc Company Overview
4.3.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
4.4 Cirle, Inc Company Overview
4.4.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview
4.5 Dutch Ophthalmic Research Center International BV Company Overview
4.5.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview
4.6 Eye Care and Cure Company Overview
4.6.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview
4.7 Hebrew University of Jerusalem Company Overview
4.7.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
4.8 Iantech Inc Company Overview
4.8.1 Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview
4.9 International BioMedical Devices Inc Company Overview
4.9.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
4.10 Medicontur Medical Engineering Ltd Company Overview
4.10.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.11 Mynosys Cellular Devices, Inc. Company Overview
4.11.1 Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.12 OptoLight Vision Technology Company Overview
4.12.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
4.13 Paradigm Medical Industries, Inc. (Inactive) Company Overview
4.13.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.14 Shanghai Haohai Biological Technology Co Ltd Company Overview
4.14.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.15 STAAR Surgical Company Company Overview
4.15.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview
4.16 Tear Diagno LLC (Inactive) Company Overview
4.16.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.17 University of California Los Angeles Company Overview
4.17.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
4.18 University of Florida Company Overview
4.18.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
4.19 University of Michigan Company Overview
4.19.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
4.20 University of Texas Medical Branch at Galveston Company Overview
4.20.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
4.21 VSY Biotechnology BV Company Overview
4.21.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview
4.22 Wake Forest Baptist Medical Center Company Overview
4.22.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5 Cataract Surgery Devices- Recent Developments
5.1 Nov 20, 2019: Baring Private Equity Asia signs agreement to buy Lumenis
5.2 Nov 19, 2019: Alcon reports third quarter and nine months 2019 results
5.3 Nov 12, 2019: Ocular Therapeutix reports third quarter 2019 financial results and business update
5.4 Nov 06, 2019: Glaukos Corporation announces third quarter 2019 financial results
5.5 Nov 04, 2019: Bausch Health Companies announces third-quarter 2019 results and raises full-year revenue and adjusted EBITDA (non-GAAP) guidance ranges
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cataract Surgery Devices - Pipeline Products by Stage of Development
Table 2: Cataract Surgery Devices - Pipeline Products by Segment
Table 3: Cataract Surgery Devices - Pipeline Products by Territory
Table 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path
Table 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date
Table 6: Cataract Surgery Devices - Ongoing Clinical Trials
Table 7: Cataract Surgery Devices Companies - Pipeline Products by Stage of Development
Table 8: Cataract Surgery Devices - Pipeline Products by Stage of Development
Table 9: Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Accupulse Cataract Emulsifier - Product Status
Table 11: Accupulse Cataract Emulsifier - Product Description
Table 12: Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: SOLO - Product Status
Table 14: SOLO - Product Description
Table 15: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: BLS - 001: Cataract - Product Status
Table 17: BLS - 001: Cataract - Product Description
Table 18: BLS - 002: Cataract - Product Status
Table 19: BLS - 002: Cataract - Product Description
Table 20: BLS - 003: Cataract - Product Status
Table 21: BLS - 003: Cataract - Product Description
Table 22: BLS - 004: Cataract - Product Status
Table 23: BLS - 004: Cataract - Product Description
Table 24: BLS - 006: Cataract - Product Status
Table 25: BLS - 006: Cataract - Product Description
Table 26: BLS - 007: Cataract - Product Status
Table 27: BLS - 007: Cataract - Product Description
Table 28: BLS - 008: Cataract - Product Status
Table 29: BLS - 008: Cataract - Product Description
Table 30: BLS - 010: Cataract - Product Status
Table 31: BLS - 010: Cataract - Product Description
Table 32: BLS - 011: Cataract - Product Status
Table 33: BLS - 011: Cataract - Product Description
Table 34: BLS - 015: Cataract - Product Status
Table 35: BLS - 015: Cataract - Product Description
Table 36: BLS - 016: Cataract - Product Status
Table 37: BLS - 016: Cataract - Product Description
Table 38: Ophthalmic Viscosurgical Device - Product Status
Table 39: Ophthalmic Viscosurgical Device - Product Description
Table 40: Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: SNS 200 - Product Status
Table 42: SNS 200 - Product Description
Table 43: Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview
Table 44: EVA Phaco-Vitrectomy System - Product Status
Table 45: EVA Phaco-Vitrectomy System - Product Description
Table 46: Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Ophthalmic Device - Cataract Surgery - Product Status
Table 48: Ophthalmic Device - Cataract Surgery - Product Description
Table 49: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Ophthalmic Viscoelastic Device - Product Status
Table 51: Ophthalmic Viscoelastic Device - Product Description
Table 52: Iantech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Reusable Cataract Surgery Device - Product Status
Table 54: Reusable Cataract Surgery Device - Product Description
Table 55: International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: ApertureRx Precision Capsulotomy System - Product Status
Table 57: ApertureRx Precision Capsulotomy System - Product Description
Table 58: Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Pre-Filled Injection System - Product Status
Table 60: Pre-Filled Injection System - Product Description
Table 61: Mynosys Cellular Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 62: ZEPTO - Product Status
Table 63: ZEPTO - Product Description
Table 64: Zepto-PEDS - Product Status
Table 65: Zepto-PEDS - Product Description
Table 66: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Lipshitz Macular Implant - Diabetic Maculopathy - Product Status
Table 68: Lipshitz Macular Implant - Diabetic Maculopathy - Product Description
Table 69: OptoLight Vision Technology - Ongoing Clinical Trials Overview
List of Figures
Figure 1: Cataract Surgery Devices - Pipeline Products by Stage of Development
Figure 2: Cataract Surgery Devices - Pipeline Products by Segment
Figure 3: Cataract Surgery Devices - Pipeline Products by Territory
Figure 4: Cataract Surgery Devices - Pipeline Products by Regulatory Path
Figure 5: Cataract Surgery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Cataract Surgery Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Advanced Refractive Technologies Inc
  • Altacor Ltd
  • Bausch & Lomb Inc
  • Cirle, Inc
  • Dutch Ophthalmic Research Center International BV
  • Eye Care and Cure
  • Hebrew University of Jerusalem
  • Iantech Inc
  • International BioMedical Devices Inc
  • Medicontur Medical Engineering Ltd
  • Mynosys Cellular Devices, Inc.
  • OptoLight Vision Technology
  • Shanghai Haohai Biological Technology Co Ltd
  • STAAR Surgical Company
  • University of California Los Angeles
  • University of Florida
  • University of Michigan
  • University of Texas Medical Branch at Galveston
  • VSY Biotechnology BV
  • Wake Forest Baptist Medical Center